Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7379)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2020 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aggarwal H, Sheffield KM, Li L, Lenis D, Sorg R, Barzi A, Miksad R. Primary tumor location and survival in colorectal cancer: A retrospective cohort study. World J Gastrointest Oncol 2020; 12(4): 405-423 [PMID: 32368319 DOI: 10.4251/wjgo.v12.i4.405] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i4/405.htm |
| Number | Citing Articles |
| 1 |
Chenghui Zhou, Liqing Lu, Qiulin Huang, Zhen Tang, Rong Tang, Zhongsheng Xiao, Shuai Xiao. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02741-3
|
| 2 |
Sigmar Stelzner, Matthias Mehdorn, Erik Puffer, Dorothea Bleyl, Thomas Kittner, Philipp Rhode, Ines Gockel, Soeren T. Mees. Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse – A multivariate analysis of a large single institution database. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-023-04590-8
|
| 3 |
Metin Deniz Karakoç, Özden Özer. METASTATİK KOLOREKTAL KANSERLİ HASTALARIN EGFR YA DA VEGF İNHİBİTÖRÜ KULLANIM DURUMLARINA GÖRE KLİNİK ÖZELLİKLERİNİN İNCELENMESİ. Kocatepe Tıp Dergisi 2023; 24(4): 466 doi: 10.18229/kocatepetip.1192194
|
| 4 |
Carles Pericay, Ana Fernández Montes, Vicente Alonso Orduña, Ismael Macias Declara, Elena Asensio Martínez, Nuria Rodríguez Salas, Esperanza Torres, Diego Cacho Lavín, Rosa María Rodríguez Alonso, Esther Falcó, Joan Carles Oliva, Lluis Cirera. Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study. Cancers 2023; 15(18): 4603 doi: 10.3390/cancers15184603
|
| 5 |
Ronen Brenner, Shlomit Amar-Farkash, Avital Klein-Brill, Keren Rosenberg-Katz, Dvir Aran. Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study. Cancer Control 2023; 30 doi: 10.1177/10732748231202470
|
| 6 |
Shukui Qin, Jin Li, Yuxian Bai, Yongqian Shu, Wei Li, Xianli Yin, Ying Cheng, Guoping Sun, Yanhong Deng, Haijun Zhong, Yunfeng Li, Xiaoping Qian, Liangming Zhang, Jingdong Zhang, Kehe Chen, Wenying Kang, Yuxian Bai, Yongqian Shu, Wei Li, Xianli Yin, Ying Cheng, Guoping Sun, Yanhong Deng, Haijun Zhong, Jin Li, Yunfeng Li, Xiaoping Qian, Shukui Qin, Liangming Zhang, Jingdong Zhang, Kehe Chen, Yuping Sun, Yuan Lin, Tianshu Liu, Li Bai, Shirong Cai, Hong Zong, Helong Zhang, Wei Wang, Sanyuan Sun, Jianping Xiong, Jianfeng Zhou, Bangwei Cao, Hongming Pan, Suxia Luo, Yi Ba, Nong Xu, Jianwei Lu, Jiemin Zhao, Tao Zhang, Zhendong Chen, Jun Liang, Qiu Li, Peiguo Cao, Dong Wang, Wangjun Liao, Yueyin Pan, Longzhen Zhang, Yan Tan, Yunpeng Liu, Xi Chen, Jianwei Yang, Tao Ma, Xiaoyan Lin, Shan Zeng, Minghui Zhang, Xiuli Wang, Enxiao Li, Yiye Wan, Guohua Yu, Weijian Guo, Ying Yuan, Yuansong Bai, Guangyu An, Jianming Xu, Lei Yang, Houjie Liang, Jiang Liu, Wenling Wang. Efficacy, Safety, and Immunogenicity of HLX04
Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment
for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III
Study. BioDrugs 2021; 35(4): 445 doi: 10.1007/s40259-021-00484-9
|
| 7 |
Xuening Zhang, Hao Zhao, Xuezhong Shi, Xiaocan Jia, Yongli Yang. Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer. Aging 2020; 12(24): 26095 doi: 10.18632/aging.202317
|
| 8 |
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Rongfa Yuan, Zhengming Zhu. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis. Acta Chirurgica Belgica 2023; 123(2): 132 doi: 10.1080/00015458.2021.1956799
|
| 9 |
Takahiko Ito, Atsuo Takashima, Kentaro Yamazaki, Hiroki Yukami, Hiroyuki Uetake, Masahiro Tsuda, Takeshi Suto, Toshikazu Moriwaki, Naotoshi Sugimoto, Hitoshi Ojima, Yasumasa Takii, Hisateru Yasui, Taito Esaki, Akihito Tsuji, Masahiro Goto, Masayuki Saruta, Satoshi Otsu, Katsunori Shinozaki, Toshiyoshi Fujiwara, Takao Tamura, Eishi Baba, Manabu Shiozawa, Tadamichi Denda, Hideki Ueno, Kengo Nagashima, Yasuhiro Shimada. Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum. International Journal of Clinical Oncology 2022; 27(9): 1450 doi: 10.1007/s10147-022-02208-7
|